The company said on April 24, 2025 its board approved the 2025-2026 Board of Directors Compensation Program. Non-management directors receive a $130,000 annual retainer for board membership, paid quarterly, and the board chair role carries a separate $100,000 annual retainer.

1. 01

   The company said on April 24, 2025 its board approved the 2025-2026 Board of Directors Compensation Program. Non-management directors receive a $130,000 annual retainer for board membership, paid quarterly, and the board chair role carries a separate $100,000 annual retainer.

2. 02

   HCA Healthcare said it grants each non-management director an annual board equity award in restricted share units valued at $220,000. The company said it expects each director to acquire common stock directly or indirectly worth 5 times the annual cash retainer within 5 years of election to the board.

3. 03

   The company said stockholders approved the first amendment to the 2020 Stock Incentive Plan on April 24, 2025 at its annual meeting. The amendment increases the number of shares of common stock that may be issued by 13,150,000 shares and extends the plan term to April 24, 2035.

4. 04

   The company said stockholders approved a charter amendment permitting exculpation of officers, which takes effect on April 25, 2025. The proposal received 190,215,349 votes for and 22,063,435 votes against.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.